Literature DB >> 5451957

Transport of sick newborn babies.

C N Storrs, M R Taylor.   

Abstract

When sick newborn babies are transferred to Hammersmith Hospital they are collected from the referring hospital or from home by a paediatric resident doctor and a nurse. They prepare the baby for the journey by giving any urgent treatment required, for procedures are difficult to carry out in a moving ambulance. Babies who are likely to become apnoeic are intubated before transport so that ventilation can be started immediately if required. The baby travels in a portable incubator, and special attention is paid to prevention of hypothermia, adequate oxygenation, and respiration. Altogether 122 babies were transferred in 1969, the main reasons being prematurity, hyaline membrane disease, and apnoeic attacks. Five improved during the journey, 102 did not change significantly and 15 became worse. There was no evidence that travel per se harmed any of the babies, though in a few cases deterioration might have been prevented had observation and treatment been easier in the ambulance. Fifty-eight (47%) of the babies eventually died, but the group was a highly selected one with a high proportion of small, immature, and ill babies. We conclude that for very ill newborn babies the advantages of transfer to an intensive care unit probably outweigh the disadvantages of transport, provided that the precautions described here are taken.

Entities:  

Mesh:

Year:  1970        PMID: 5451957      PMCID: PMC1701480          DOI: 10.1136/bmj.3.5718.328

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  EFFECT OF MAINTENANCE OF "NORMAL" SKIN TEMPERATURE ON SURVIVAL OF INFANTS OF LOW BIRTH WEIGHT.

Authors:  K C BUETOW; S W KLEIN
Journal:  Pediatrics       Date:  1964-08       Impact factor: 7.124

2.  BODY TEMPERATURE AND SURVIVAL OF PREMATURE INFANTS.

Authors:  R L DAY; L CALIGUIRI; C KAMENSKI; F EHRLICH
Journal:  Pediatrics       Date:  1964-08       Impact factor: 7.124

3.  The influence of the thermal environment upon the survival of newly born premature infants.

Authors:  W A SILVERMAN; J W FERTIG; A P BERGER
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

4.  Dextrostix in the diagnosis of neonatal hypoglycaemia.

Authors:  C Chantler; J D Baum; D A Norman
Journal:  Lancet       Date:  1967-12-30       Impact factor: 79.321

5.  The silver swaddler. Device for preventing hypothermia in the newborn.

Authors:  J D Baum; J W Scopes
Journal:  Lancet       Date:  1968-03-30       Impact factor: 79.321

6.  Growth of the human fetus. I. Normal growth and its variation.

Authors:  P Gruenwald
Journal:  Am J Obstet Gynecol       Date:  1966-04-15       Impact factor: 8.661

7.  The significance of grunting in hyaline membrane disease.

Authors:  V C Harrison; H de V Heese; M Klein
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

8.  Transfer of a premature or other high-risk newborn infant to a referral hospital.

Authors:  S Segal
Journal:  Pediatr Clin North Am       Date:  1966-11       Impact factor: 3.278

  8 in total
  6 in total

1.  Simplified ECG monitoring with an electrode mat.

Authors:  A J Macnab; R Pope
Journal:  Br Med J       Date:  1976-08-28

2.  A better deal for newborns with congenital heart disease.

Authors:  F Macartney
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

3.  The small-for-dates baby. II.

Authors:  R Robinson
Journal:  Br Med J       Date:  1971-11-20

4.  Air transport of infants in Newfoundland and Labrador.

Authors:  M A Johnson; J Owers; P Horwood
Journal:  Can Med Assoc J       Date:  1978-07-22       Impact factor: 8.262

5.  Transport of newborn infants for intensive care.

Authors:  A M Blake; N McIntosh; E O Reynolds; D S Andrew
Journal:  Br Med J       Date:  1975-10-04

6.  Neurological sequelae in children surviving mechanical ventilation in the neonatal period.

Authors:  K J Marriage; P A Davies
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.